STOCK TITAN
  1. Home
  2. Sec-filings
  3. QTRX
  4. [8-K] Quanterix Corp Reports Material Event

Quanterix (QTRX) CFO Vandana Sriram to depart in June 2026 after planned transition

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Quanterix Corporation announced that Chief Financial Officer and Treasurer Vandana Sriram will leave the company, with her role ending on June 15, 2026. She will stay through that date to support a smooth transition while the company conducts a search for her successor with an executive search firm.

Under her employment agreement, Ms. Sriram will receive 12 months of base salary, an amount equal to her annual target bonus for 2026, and subsidized health benefits for 12 months. The company states that her departure is not related to any disagreements regarding accounting practices, financial statements, internal controls, or operations, and highlights that Quanterix remains on solid financial footing with a focus on cash flow breakeven and synergy targets.

Positive

  • None.

Negative

  • None.

Insights

CFO transition is structured and non-dispute related, signaling orderly succession.

Quanterix disclosed a planned CFO departure effective June 15, 2026, with the executive remaining in place to ensure continuity. The company is using a leading executive search firm to recruit a successor, suggesting an organized approach to leadership succession.

The filing specifies that the departure is not tied to accounting, controls, or operational disagreements, which can reassure investors compared with abrupt or contentious exits. Severance terms follow her employment agreement, including 12 months of base salary, a 2026 target bonus amount, and 12 months of subsidized health benefits.

In the accompanying comments, management emphasizes solid financial footing, a clear path to cash flow breakeven, and progress on synergy targets. While these statements are qualitative, they frame the transition as occurring from a position of operational and financial discipline rather than distress.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
CFO transition date June 15, 2026 Effective date when Vandana Sriram ceases serving as CFO and Treasurer
Severance salary period 12 months Continued base salary payable after CFO departure under employment agreement
Health benefits period 12 months Subsidized health benefits provided following CFO departure
Annual target bonus reference 2026 target bonus Cash amount equal to 2026 annual target bonus included in severance
severance benefits financial
"Ms. Sriram will receive severance benefits in accordance with the terms of her employment agreement"
annual target bonus financial
"payment of an amount equal to her annual target bonus for 2026"
Regulation FD Disclosure regulatory
"Item 7.01 Regulation FD Disclosure."
Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.
cash flow breakeven financial
"with a clear path to cash flow breakeven and achievement of challenging synergy targets"
synergy targets financial
"clear path to cash flow breakeven and achievement of challenging synergy targets"
internal controls regulatory
"not related to any disagreements with the Company on any matter relating to its accounting practices, financial statements, internal controls, or operations"
Internal controls are the policies, procedures and routine checks a company uses to keep its financial records accurate, safeguard assets, and ensure laws and internal rules are followed. For investors they matter because strong controls reduce the risk of accounting errors, fraud or surprise liabilities; think of them as locks, alarms and bookkeeping checklists that make a company’s reported results more trustworthy and lower the chance of unexpected losses.
Understanding 8-K Material Events →
Quanterix Corpfalse000150327400015032742026-05-112026-05-11

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________
FORM 8-K
______________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 11, 2026
_________________________________________________
QUANTERIX CORPORATION
(Exact name of registrant as specified in its charter)
_________________________________________________
Delaware001-3831920-8957988
(State or other jurisdiction
of incorporation)		(Commission File Number)(IRS Employer
Identification No.)
900 Middlesex Turnpike
Billerica, MA
01821
(Address of principal executive offices)
(Zip Code)
(617) 301-9400
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class:
Trading symbol(s):
Name of each exchange on which
registered:
Common Stock, $0.001 par value per shareQTRXThe Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 5.02    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Vandana Sriram will be leaving Quanterix Corporation (the “Company”) and will no longer serve as the Chief Financial Officer and Treasurer of the Company effective June 15, 2026. Ms. Sriram will receive severance benefits in accordance with the terms of her employment agreement with the Company, as amended, consisting of the continued payment of her base salary for 12 months, payment of an amount equal to her annual target bonus for 2026, and subsidized health benefits for 12 months.
Ms. Sriram’s departure is not related to any disagreements with the Company on any matter relating to its accounting practices, financial statements, internal controls, or operations.
The Company is conducting a search, with the assistance of a leading executive search firm, to identify a successor for the Chief Financial Officer position.
Item 7.01    Regulation FD Disclosure.
On May 12, 2026, the Company issued a press release, which announced the pending departure of Ms. Sriram (the “Release”). A copy of the Release is attached as Exhibit 99.1 and incorporated herein by reference.
The information contained or incorporated in this Item 7.01, including Exhibit 99.1, is being furnished, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01    Financial Statements and Exhibits.
(d)Exhibits
Exhibit
No.		Description
99.1
Press Release dated May 12, 2026.
104Cover Page Interactive Data File (embedded within the inline XBRL document)


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: May 12, 2026
QUANTERIX CORPORATION
By:/s/ Daniel S. Char
Name:
Daniel S. Char
Title:
Chief Legal Officer and Corporate Secretary

Exhibit 99.1
Quanterix Announces Planned Transition of Chief Financial Officer
BILLERICA, Mass.--May 12, 2026-- Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that Vandana Sriram, its Chief Financial Officer (“CFO”) will depart the Company. A search for her successor is ongoing, and Ms. Sriram will continue as CFO through June 15, 2026, to ensure continuity and a successful transition.
"Vandana has made impactful contributions to Quanterix since joining the Company in 2023,” stated Everett Cunningham, President and Chief Executive Officer of Quanterix. “Her leadership and contributions have been instrumental in the ongoing evolution of the company and have helped create a strong foundation for cost discipline and cash management. I thank Vandana for her partnership during my tenure as CEO and wish her the very best in her next professional endeavor."
"Quanterix is on a solid financial footing, with a clear path to cash flow breakeven and achievement of challenging synergy targets and operating with solid financial discipline and rigor. I am honored to have worked with such a talented and dedicated team," commented Vandana Sriram. "It has been a privilege to be part of the company’s journey, and I look forward to seeing the company’s continued success."
About Quanterix
Quanterix is a global leader in ultra-sensitive biomarker detection, enabling breakthroughs in disease research, diagnostics, and drug development. Its proprietary Simoa® technology delivers industry-leading sensitivity, allowing researchers to detect and quantify biomarkers in blood and other fluids at concentrations far below traditional limits. With approximately 6,300 peer-reviewed publications, Quanterix has been a trusted partner to the scientific community for nearly two decades. In 2025, Quanterix acquired Akoya Biosciences, The Spatial Biology Company®, adding multiplexed tissue imaging with single-cell resolution to its portfolio and 1,439 installed instruments. Together, the combined company offers a uniquely integrated platform that connects biology across blood and tissue—advancing precision medicine from discovery to diagnostics. Learn more at www.quanterix.com.

Media
media@quanterix.com
Investor Relations
Joshua Young
ir@quanterix.com

Source: View Original Filing on SEC EDGAR

FAQ

Why is Quanterix (QTRX) changing its Chief Financial Officer?

Quanterix disclosed that CFO Vandana Sriram will depart effective June 15, 2026. The company states her departure is not due to disagreements over accounting, financial statements, internal controls, or operations, framing it as a planned leadership transition rather than a dispute-driven change.

When will Quanterix (QTRX) CFO Vandana Sriram leave her role?

Vandana Sriram will continue serving as Quanterix’s CFO and Treasurer through June 15, 2026. She will remain in the position until that date to help ensure continuity and a successful handover while the company conducts a search for her successor.

What severance will Quanterix (QTRX) CFO Vandana Sriram receive?

Under her employment agreement, Vandana Sriram will receive 12 months of base salary, an amount equal to her 2026 annual target bonus, and subsidized health benefits for 12 months. These terms are described as consistent with the agreement as amended with Quanterix.

Did Quanterix (QTRX) report any disagreements linked to the CFO’s departure?

Quanterix explicitly states that Vandana Sriram’s departure is not related to disagreements about accounting practices, financial statements, internal controls, or operations. This language indicates the transition is not being driven by reported disputes over financial reporting or control issues.

How is Quanterix (QTRX) handling the search for a new CFO?

Quanterix is conducting a search for a new Chief Financial Officer with help from a leading executive search firm. During this process, Vandana Sriram will continue as CFO through June 15, 2026, supporting continuity until a successor is identified and onboarded.

What does Quanterix (QTRX) say about its financial position during this CFO transition?

In the press release, Quanterix highlights that it is on solid financial footing, with a clear path to cash flow breakeven and challenging synergy targets, and operating with financial discipline. These are qualitative statements from management accompanying the announced CFO transition.

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents